The Leadership Team at Amagma drives the strategic vision and operational excellence of the company, focusing on advancing antibody-based therapies to meet critical clinical needs. Comprised of experienced leaders, including the Chief Scientific Officer and Chief Business Officer, this team collaborates to oversee research initiatives, business development, and the overall innovation strategy, ensuring that Amagma remains at the forefront of antibody research and application.
View all